We describe the results of a qualitative study that explored the knowledge and views 20 adults with learning disabilities and their carers had of medication prescribed for behaviour problems. We found that the adults with mild and moderate learning disabilities can provide sensible, consistent and valuable information about their thoughts and experiences of medication prescribed when questions are asked in an open‐ended format. We also found that few people with learning disabilities were fully informed about their treatment. Nevertheless, the prescribing of such medication emerged as a positive experience, in keeping with the wishes of the majority of participants interviewed who expressed satisfaction with the medication based on perceived benefit. For the minority of participants who expressed dissatisfaction with medication, the reasons related mainly to their perceived lack of role in the treatment decision, their experience of adverse effects, a perceived lack of efficacy and a ‘desire to lead a normal life’. Alternatives to medication were discussed by both adults with learning disabilities and their carers, and the relevance of these findings to clinical practice is addressed in the paper.
Article navigation
1 March 2008
Review Article|
March 01 2008
A qualitative study on the knowledge and views that people with learning disabilities and their carers have of psychotropic medication prescribed for behaviour problems Available to Purchase
Sylvia Hall;
Sylvia Hall
South Staffordshire and Shropshire Healthcare NHS Foundation Trust
Search for other works by this author on:
Shoumitro Deb
Shoumitro Deb
Division of Nueroscience, University of Birmingham, UK
Search for other works by this author on:
Online ISSN: 2042-8332
Print ISSN: 1753-0180
© Emerald Group Publishing Limited
2008
Advances in Mental Health and Learning Disabilities (2008) 2 (1): 29–37.
Citation
Hall S, Deb S (2008), "A qualitative study on the knowledge and views that people with learning disabilities and their carers have of psychotropic medication prescribed for behaviour problems". Advances in Mental Health and Learning Disabilities, Vol. 2 No. 1 pp. 29–37, doi: https://doi.org/10.1108/17530180200800005
Download citation file:
Suggested Reading
STOMP during COVID-19: use of psychotropic medication in intellectual disabilities community services – pilot QI project
Advances in Mental Health and Intellectual Disabilities (April,2024)
Developing services for people with dementia: Findings from research in a rural area
Quality of Ageing (December,2008)
Adjustment of the UKU Side Effect Rating Scale for adults with intellectual disabilities. A pilot study
Advances in Mental Health and Intellectual Disabilities (July,2014)
Staff perceptions of PRN medication in a residential care setting
The Journal of Mental Health Training, Education and Practice (October,2019)
The use of psychotropic medication for the management of problem behaviours in adults with intellectual disabilities living in Canada
Advances in Mental Health and Intellectual Disabilities (September,2010)
Related Chapters
Changes After COVID-19 on Welfare Policies and Services for People With Learning Disabilities and Autism: A Case Study for England, United Kingdom
Disability Welfare Policy in Europe: Cognitive Disability and the Impact of the Covid-19 Pandemic
Transition to Junior Secondary Schooling for Students with Learning Difficulties and Disabilities: A Study in Personalised Learning and Building Relational Agency in Schools
Inclusive Principles and Practices in Literacy Education
Using Technology to Enhance Learning for Students With Learning Disabilities
Using Technology to Enhance Special Education
Recommended for you
These recommendations are informed by your reading behaviors and indicated interests.
